{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:25:39Z","timestamp":1759623939155,"version":"build-2065373602"},"reference-count":42,"publisher":"Oceanside Publications Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> It is critical for rescue medications to have rapid absorption and onset of action. Although intranasal formulations of rescue medications have advantages over other forms of administration, the impact of nasal congestion on drug absorption has been questioned.\n  <jats:bold>Objective:<\/jats:bold> We aimed to determine if nasal congestion impacts the absorption and efficacy of intranasal rescue medications.  <jats:bold>Methods:<\/jats:bold> A rescue medication is used as needed for the immediate treatment of an episodic medical event that requires urgent intervention.\n Systematic searches for 15 pre-identified intranasal rescue medications were conducted in PubMED\/MEDLINE up to July 2, 2024. Eligible studies were controlled human studies that compared the absorption or efficacy of an identical dose of intranasal rescue medication administered with and without\n the presence of nasal congestion that was induced by allergen challenge or that was associated with a medical condition (e.g., allergic rhinitis).  <jats:bold>Results:<\/jats:bold> The searches identified 160 articles; six studies, all open-label, were eligible for final inclusion. Two intranasal\n epinephrine studies showed increased maximum plasma concentrations after allergen-induced congestion; one of these epinephrine studies also showed a faster time to maximum plasma concentration. Three additional studies that evaluated epinephrine, glucagon, and fentanyl found no effect of congestion\n on absorption. In the sixth study, congestion had no effect on zolmitriptan efficacy.  <jats:bold>Conclusion:<\/jats:bold> Available evidence indicates no negative impact of nasal congestion on the absorption of intranasal rescue medications. Congestion may actually increase absorption of some\n intranasal epinephrine formulations. The impact of congestion on intranasal medication absorption is likely dependent on each drug\u2019s properties, mode of action, and formulation.<\/jats:p>","DOI":"10.2500\/aap.2025.46.250061","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:36:17Z","timestamp":1758083777000},"page":"388-397","source":"Crossref","is-referenced-by-count":1,"title":["Impact of nasal congestion on intranasal rescue medication absorption and efficacy: A systematic review"],"prefix":"10.2500","volume":"46","author":[{"given":"Michael","family":"Blaiss","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, Medical College of Georgia, Augusta, Georgia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nova Southeastern University, Davie, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph K.","family":"Han","sequence":"additional","affiliation":[{"name":"Division of Rhinology and Endoscopic Sinus-Skull Base Surgery and Allergy, Department of Otolaryngology, Eastern Virginia Medical School, Norfolk, Virginia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Rance","sequence":"additional","affiliation":[{"name":"Bryn Pharma, Lebanon, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaip.2019.12.015","article-title":"Epinephrine in the management of anaphylaxis","volume":"8","author":"Brown","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","article-title":"Anaphylaxis: a 2023 practice parameter update","volume":"132","author":"Golden","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B3","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis\u2014a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2222.2011.03743.x","article-title":"Epinephrine auto-injector use in adolescents at risk of anaphylaxis: a qualitative study in Scotland, UK","volume":"41","author":"Gallagher","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"B5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.aller.2019.07.009","article-title":"Physicians prescribe adrenaline autoinjectors, do parents use them when needed?","volume":"48","author":"Esenboga","year":"2020","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B6","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.jaip.2021.01.038","article-title":"Community use of epinephrine for the treatment of anaphylaxis: a review and meta-analysis","volume":"9","author":"Miles","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B7","doi-asserted-by":"crossref","first-page":"100581","DOI":"10.1016\/j.ebr.2022.100581","article-title":"The nose has it: opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters","volume":"21","author":"Chung","year":"2023","journal-title":"Epilepsy Behav Rep"},{"key":"B8","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"B9","first-page":"7","article-title":"Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?","volume":"7","author":"Ma","year":"2020","journal-title":"Mil Med Res"},{"key":"B10","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jaip.2024.02.038","article-title":"Upper respiratory tract infections have minimal impact on neffy's pharmacokinetics or pharmacodynamics","volume":"12","author":"Oppenheimer","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1526-4610.2005.05005.x","article-title":"Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial","volume":"45","author":"Dowson","year":"2005","journal-title":"Headache"},{"key":"B12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.anai.2024.04.033","article-title":"Randomized trial of pharmacokinetic and pharmacodynamic effects of 13.2 mg intranasal epinephrine treatment in congestion","volume":"133","author":"Dworaczyk","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/dom.13134","article-title":"Effects of common cold and concomitant administration of nasal decongestant on the pharmacokinetics and pharmacodynamics of nasal glucagon in otherwise healthy participants: a randomized clinical trial","volume":"20","author":"Guzman","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"B14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5414\/CP201825","article-title":"Impact of allergic rhinitis and its treatment on the pharmacokinetics of nasally administered fentanyl","volume":"51","author":"Perelman","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B15","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.jaip.2023.06.044","article-title":"Fast acting, dry powder, needle-free, intranasal epinephrine spray: a promising future treatment for anaphylaxis","volume":"11","author":"Tal","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"year":"2024","key":"B16"},{"key":"B17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/IJGM.S8088","article-title":"Pathophysiology of nasal congestion","volume":"3","author":"Naclerio","year":"2010","journal-title":"Int J Gen Med"},{"key":"B18","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/cea.12780","article-title":"Pathogenesis of rhinitis","volume":"46","author":"Eifan","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"B19","first-page":"97","article-title":"An update on the pathophysiology of rhinovirus upper respiratory tract infections","volume":"37","author":"van Kempen","year":"1999","journal-title":"Rhinology"},{"key":"B20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.otc.2018.05.001","article-title":"Anatomy and physiology of nasal obstruction","volume":"51","author":"Hsu","year":"2018","journal-title":"Otolaryngol Clin North Am"},{"key":"B21","first-page":"333","article-title":"A review on intranasal drug delivery system","volume":"3","author":"Appasaheb","year":"2013","journal-title":"J Adv Pharm Edu Res"},{"key":"B22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2273.2001.00509.x","article-title":"The effect of inferior turbinate hypertrophy on nasal spray distribution to the middle meatus","volume":"26","author":"Dowley","year":"2001","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"B23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","article-title":"Physicochemical properties of mucus and their impact on transmucosal drug delivery","volume":"532","author":"Leal","year":"2017","journal-title":"Int J Pharm"},{"key":"B24","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaci.2017.08.039","article-title":"Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis","volume":"141","author":"Steelant","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B25","doi-asserted-by":"crossref","first-page":"e0132367","DOI":"10.1371\/journal.pone.0132367","article-title":"Histamine induces vascular hyperpermeability by increasing blood flow and endothelial barrier disruption in vivo","volume":"10","author":"Ashina","year":"2015","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF03049581","article-title":"Nasal mucociliary clearance in health and disease","volume":"58","author":"Pandya","year":"2009","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"B27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF00315315","article-title":"The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis","volume":"45","author":"Shyu","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"B28","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s40262-023-01273-z","article-title":"Pharmacokinetics of nasal esketamine in patients with allergic rhinitis with and without nasal decongestant pretreatment and in healthy subjects with and without nasal corticosteroid pretreatment","volume":"62","author":"Zannikos","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"B29","doi-asserted-by":"crossref","first-page":"E349","DOI":"10.5489\/cuaj.4898","article-title":"Phase 1 pharmacokinetics and phase 3 efficacy of testosterone nasal gel in subjects with seasonal allergies","volume":"12","author":"Rogol","year":"2018","journal-title":"Can Urol Assoc J"},{"key":"B30","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jaci.2023.08.007","article-title":"Pharmacokinetics\/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection","volume":"152","author":"Casale","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"crossref","first-page":"100200","DOI":"10.1016\/j.jacig.2023.100200","article-title":"A 13.2 mg intranasal epinephrine spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to 0.3 mg epinephrine autoinjector","volume":"3","author":"Dworaczyk","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"article-title":"ARS-1 (intranasal epinephrine) FDA Briefing Document NDA\/BLA# 214697","key":"B32"},{"year":"2013","journal-title":"Full Prescribing Information","article-title":"Stadol NS (butorphanol tartrate) nasal spray","key":"B33"},{"year":"2013","journal-title":"1.5 mg\/mL. Full Prescribing Information","article-title":"Stimate (desmopressin acetate) nasal spray","key":"B34"},{"year":"2023","journal-title":"Full Prescribing Information","article-title":"Valtoco (diazepam nasal spray), CIV","key":"B35"},{"year":"2021","journal-title":"Full Prescribing Information","article-title":"Lazanda (fentanyl) nasal spray CII","key":"B36"},{"year":"2020","journal-title":"Full Prescribing Information","article-title":"Baqsimi (glucagon) nasal powder","key":"B37"},{"year":"2021","journal-title":"Full Prescribing Information","article-title":"Sprix (ketorolac tromethamine) nasal spray","key":"B38"},{"year":"2023","journal-title":"Full Prescribing Information","article-title":"Nayzilam (midazolam) nasal spray, CIV","key":"B39"},{"year":"2023","journal-title":"Full Prescribing Information","article-title":"Narcan (naloxone hydrochloride) nasal spray","key":"B40"},{"year":"2024","journal-title":"Full Prescribing Information","article-title":"Imitrex (sumatriptan) nasal spray","key":"B41"},{"year":"2019","journal-title":"Full Prescribing Information","article-title":"Zomig (zolmitriptan) nasal spray","key":"B42"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2025\/00000046\/00000005\/art00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:39:28Z","timestamp":1759552768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2025.46.250061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9,1]]}},"alternative-id":["1088-5412(20250901)46:5L.388;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2025.46.250061","relation":{},"ISSN":["1088-5412"],"issn-type":[{"type":"print","value":"1088-5412"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}